The density of Foxp3- CD4+ helper T cells in the tumor margin rather than the tumor center and stroma has previously shown the best capacity for predicting the treatment response in biliary tract cancer patients, and the tumor margin may be the main site of the immune response in these cases (43). The gene discussed is CD4; the disease is biliary tract neoplasm.